Sunday, October 2, 2022

Hospital seeks volunteers for early memory loss study

NEWPORT BEACH, California. Hoag Hospital is looking for volunteers to take part in a study to test an investigative treatment aimed at preventing the earliest stages of memory loss due to Alzheimer’s disease.

The research is being conducted in collaboration with Hoag’s Pickup Family Neurosciences Institute, the National Institutes of Health (NIH) and Eisai Inc., a US subsidiary of Eisai Co., headquartered in Tokyo, Japan.

Called the AHEAD study, this is the first study of Alzheimer’s disease that recruits adults over the age of 55 who are at risk of developing systems of the disease as they get older.

Researchers working on the study found that changes in the brains of people with Alzheimer’s disease can start up to 20 years before they notice obvious symptoms such as memory problems.

Participants will receive a customized dose of the study treatment, instead of a one-time approach, and will be enrolled in one of two trials, depending on the level of amyloid in their brain.

The study will be conducted in the US, Japan, Canada, Australia, Singapore and Europe. Hoag was selected to participate in the parallel 216-week study, in part because of the well-known Orange County Vital Brain Aging Program and its successful complex clinical trials.

“Hoag is a pioneer in a program to maintain cognitive health as we age, and to combat the community’s fear of Alzheimer’s disease and related disorders, through the Orange County Vital Brain Program,” said Dr. Hoag CEO Michael Brant-Zawadzki said in a press release.

“As a result, we can offer our community unique opportunities to participate in studies such as the AHEAD study. This is in line with the mission of our Institute, and we are very excited to be part of this groundbreaking work to identify ways to prevent Alzheimer’s disease. ”

According to the Alzheimer’s AssociationIt is a long and frustrating process to get an accurate diagnosis of early onset Alzheimer’s.

Symptoms of the disease can be mistakenly attributed to stress, or there may be conflicting diagnoses from different healthcare professionals for patients who are at any stage of the disease, as it affects each person differently with different symptoms.

“The adapted approach of this study, which began with treatment years before memory loss began, may be the breakthrough in our quest to prevent Alzheimer’s disease,” said Dr. William R. Shankle, Hoag’s program director of Ho memory and cognitive, said. deviations.

Among the top 10 causes of death in the United States, experts believe that Alzheimer’s is the only disease that currently cannot be prevented, cured or dramatically delayed, making trials an important element in understanding the causes and potential treatments. .

People between the ages of 55 and 80 can be eligible for Hoag’s trial if they meet certain criteria. For more information, send an email to [email protected]


Nation World News Desk
Nation World News Desk
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news
- Advertisement -